SCHEMBL8565993

SCHEMBL8565993

CCC1(c2ccc(C(=O)OC)cc2)CNC(=O)N1c1ccc2c(c1)CCN(C(=O)C(F)(F)F)CC2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 3/20 0.40
ESR2 Q92731 3/20 0.40
HDAC6 Q9UBN7 2/20 0.36
MMP2 P08253 1/20 0.33
MMP3 P08254 1/20 0.33
MMP9 P14780 1/20 0.33
MMP13 P45452 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.32
GAA P10253 2/20 0.32
KMT2A Q03164 2/20 0.32
ALDH1A1 P00352 1/20 0.32
SLC2A1 P11166 1/20 0.32
HDAC8 Q9BY41 1/20 0.32
LMNA P02545 1/20 0.32
THRB P10828 1/20 0.32
TSHR P16473 1/20 0.32
MAPK1 P28482 1/20 0.32
TP53 P04637 1/20 0.32
OPRM1 P35372 1/20 0.32
OPRL1 P41146 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8562282 0.78 ESR1 (0.35) ESR1ESR2KMT2AALDH1A1TSHR
SCHEMBL8561721 0.73 ESR1 (0.40) ESR1ESR2HDAC6KMT2AHDAC8
SCHEMBL8561377 0.73 ESR1 (0.41) ESR1ESR2HDAC6ALDH1A1SLC2A1
SCHEMBL8563245 0.72 ESR1 (0.38) ESR1ESR2HDAC6SMN1; SMN2ABHD6
SCHEMBL8565997 0.71 ESR1 (0.40) ESR1ESR2HDAC6SMN1; SMN2HDAC8
SCHEMBL8558357 0.71 ESR1 (0.37) ESR1ESR2HDAC6
SCHEMBL8563060 0.70 HDAC1 (0.45) ESR1ESR2HDAC6
SCHEMBL8566035 0.70 ESR1 (0.40) ESR1ESR2HDAC6SMN1; SMN2ACACB
SCHEMBL8559515 0.69 HTR6 (0.39)
SCHEMBL5359582 0.68 ESR1 (0.65) ESR1ESR2HDAC6HDAC8MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5827849-A HAVING INHIBITORY EFFECT ON INFLAMMATION AND BONE DEGRADATION, ANTITHROMBOTIC, ANTIAGGREGATORY AND TUMOR- OR METASTASIS-INHIBITING EFFECT KARL THOMAE GMBH (DE) 1998-10-27 US disclosed